Billings Clinic
Especially For:

Clinical Trials

Title   GU: 9785-CL-0222 Abiaterone for mildly symptomatic
Description     9785-CL-0222 Phase II Study of MDV3100A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 (ASP9785) vs. Bicalutamide in Castrate Men with Metastatic Prostate Cancer
IRB Number   SWOG S1014
Category   Genitourinary
Inclusion/Notes   Must have metastatic or progressive disease per Astellas definition, Must be on LHRH (may start @ screening) or orchiectomy, Only mildly symptomatic, w/ PSA of 0-1 No antiandrogen therapy (unless used less that 12 wks) & DC’d no less than 6 mo prior to screening, No ketoconazole , ever, Rt ok if more than 30 days have passed , No seizures
Status   Active
Start Date   01/09/2012
Principal Investigator (PI)   Jorge Nieva, MD
Contact Name   Judy Miller,RN
Contact Email
Phone   (406) 435-7482
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.